SPRO Next Earnings Date Notes

— Spero Therapeutics (SPRO) is a clinical-stage biopharmaceutical company focused on developing novel treatments for serious bacterial infections, with an emphasis on addressing the growing threat of antibiotic resistance. The company’s lead asset is tebipenem HBr, an oral carbapenem antibiotic candidate aimed at multi-drug resistant (MDR) Gram-negative infections, particularly complicated urinary tract infections (cUTIs). Spero also has early-stage intravenous programs and collaborations with global pharmaceutical leaders. For investors tracking SPRO, key business metrics include cash runway & liquidity (to gauge near-term sustainability), pipeline advancement milestones (such as clinical trial results and regulatory submission updates), partnership revenues (especially from alliances with companies like Pfizer), and the status of FDA reviews. Investors should also watch for updates on commercial launch readiness if tebipenem HBr advances toward approval. On the upcoming earnings call, special attention should be given to guidance around regulatory timelines, R&D expense forecasts, and management perspectives on business development opportunities—these factors are critical for evaluating SPRO’s prospects amid the challenging antibiotics market. The next confirmed earnings date for SPRO is 5/13/2026 after close.

SPRO Next Earnings Date FAQ

On this page we presented the SPRO Next Earnings Date information for Spero Therapeutics along with recent past earnings dates. For Q4 of 2025, SPRO reported earnings of 0.530/share, with the earnings report taking place on 3/26/2026. For Q3 of 2025, SPRO reported earnings of -0.130/share, with the earnings report taking place on 11/13/2025. For Q2 of 2025, SPRO reported earnings of -0.030/share, with the earnings report taking place on 8/12/2025. For Q1 of 2025, SPRO reported earnings of -0.250/share, with the earnings report taking place on 5/13/2025. For Q4 of 2024, SPRO reported earnings of -0.380/share, with the earnings report taking place on 3/27/2025. And with these past earnings dates behind SPRO, investors can look ahead to the next confirmed earnings date of 5/13/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Spero Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Spero Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Spero Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next SPRO earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up SPRO's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the SPRO next earnings date.